Spero Therapeutics, Inc.

NasdaqGS:SPRO Stock Report

Market Cap: US$65.4m

Spero Therapeutics, Inc. Company Information

Spero Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Spero Therapeutics, Inc.
  • Ticker: SPRO
  • Exchange: NasdaqGS
  • Founded: 2013
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$65.422m
  • Shares Outstanding: 54.52m
  • Website: https://sperotherapeutics.com

Number of Employees

Location

  • Spero Therapeutics, Inc.
  • 675 Massachusetts Avenue
  • 14th Floor
  • Cambridge
  • Massachusetts
  • 02139
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SPRONasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDNov 2017
2HADB (Deutsche Boerse AG)YesCommon StockDEEURNov 2017

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/21 23:11
End of Day Share Price 2024/11/21 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.